Vitaspring Biomedical Statements
VS
Data from Vitaspring Biomedical`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
31 Oct, 2022
Next reporting period:
29 Jan, 2023
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
—
Vitaspring Biomedical Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
-100 %
100
—
0
—
-100 %
0
—
0
0.183
0
0.183
-54.2 %
0
-0.183
-208.7 %
0
—
0
-0.001
0
-0.184
-203.8 %
0
-0.046
0
-0.138
-204.4 %
0
-0.001
206.52
1.49
—
100
0.922
61.9
0.568
—
38.1
—
0
0.4
26.8
0.4
77.7 %
26.8
0.168
-50.9 %
11.3
—
0
0.009
0.6
0.177
-49.7 %
11.9
0.045
3
0.132
-52.2 %
8.9
0.001
206.52
1.49
-57.3 %
100
0.922
61.9
0.568
-61.3 %
38.1
—
0
0.221
14.8
0.225
-19.3 %
15.1
0.343
-71.1 %
23
—
0
0.009
0.6
0.352
-70.4 %
23.6
0.075
5
0.277
-70.6 %
18.6
0.001
206.52
3.489
1641 %
100
2.022
58
1.467
7091.2 %
42
—
0
0.278
8
0.279
77 %
8
1.188
967 %
34.1
—
0
—
0
1.188
967 %
34.1
0.247
7.1
0.941
786.9 %
27
0.005
206.53
0.2
-89.6 %
100
0.18
89.8
0.02
-96.5 %
10.2
—
0
0.157
78.4
0.157
4.5 %
78.6
-0.137
-131.9 %
-68.4
—
0
—
0
-0.137
-131.9 %
-68.4
—
0
-0.137
-129.8 %
-68.4
-0.001
206.52
1.924
260.4 %
100
1.343
69.8
0.581
142.1 %
30.2
—
0
0.149
7.8
0.151
149.6 %
7.8
0.43
139.6 %
22.3
—
0
—
0
0.43
139.6 %
22.3
-0.03
-1.5
0.46
162.7 %
23.9
0.002
206.16
0.534
—
100
0.294
55.1
0.24
—
44.9
—
0
0.06
11.2
0.06
—
11.3
0.179
—
33.6
—
0
—
0
0.179
—
33.6
0.004
0.8
0.175
—
32.8
0.001
205.45